Insertable ultrasound probes, systems, and methods for thermal therapy

• US 20050240170A1
• Filed: 09/24/2003
• Published: 10/27/2005
• Est. Priority Date: 10/25/1999
• Status: Abandoned Application

• Current Assignee: Otsuka Medical Devices Co., Ltd. (Otsuka Holdings Company Limited)
• Original Assignee: Therus Corp. (Boston Scientific Corporation)
• Inventors: Zhang, Jimin, Perozek, David M., Weng, Lee
• Application Number:
  US10/671,417
• Publication Number:
  US 20050240170A1
• Time in Patent Office: Days
• US Class Current: 606/27
• CPC Class Codes: A61B 17/22012 in direct contact with, or very close to, the obstruction or concrement for removing obstructions in blood vessels by laser A61B18/245
• CPC Class Codes: A61B 2090/378 using ultrasound
• CPC Class Codes: A61N 7/022 intracavitary

Abstract

Disclosed herein are methods and systems for producing hemostasis, tissue closure, or vessel closure by inserting a thermal delivery probe into a passageway and emitting thermal energy from the probe to produce the hemostasis or tissue closure. These methods and systems may be used following a percutaneous medical procedure that creates a passageway in tissue of patient, such as is caused by introduction of an access device into the patient. The thermal delivery probe may have one or more ultrasound transducers positioned in an elongated shaft.

Claims

1. A method for producing hemostasis, tissue closure, and/or vessel closure following a percutaneous medical procedure wherein an access device is introduced to a patient creating a passageway, said method comprising the step of:

a) inserting a thermal delivery probe into the passageway;

b) determining a site at which thermal energy should be applied;

c) emitting sufficient thermal energy to the site in order to raise native tissue temperatures; and

d) inducing tissue and/or blood coagulation at the site.

2. The method of claim 1, wherein the step of determining the site at which thermal energy should be applied, further comprises ultrasonically interrogating a section of the passageway using pulsed Doppler.

3. The method of claim 2, wherein the passageway was created in order to access a femoral, brachial or peripheral vessel.

4. The method of claim 3, wherein thermal delivery probe has an outer diameter of about 4-10 French or larger.

5. The method of claim 4, wherein the emitted thermal energy is ultrasonically applied using a high frequency, high power output ultrasound transducer.

6. The method of claim 2, wherein the emitted thermal energy is ultrasonically applied using a high frequency, high power output ultrasound transducer.

7. The method of claim 5 or 6, wherein the high frequency, high power output ultrasound transducer is located at a distal end of the thermal delivery probe.

8. The method of claim 5, wherein the high frequency, high power output ultrasound transducer is operated at about 6 MHz and output about 2 W/cm².

9. The method of claim 6, wherein the high frequency, high power output ultrasound transducer is operated at about 6 MHz and output about 2 W/cm².

10. A method for producing hemostasis and tissue closure following a percutaneous medical procedure wherein an access device is introduced to a patient creating a passageway, said method comprising the following step:

a) inserting a ultrasound probe into the passageway;

b) determining a site at which thermal energy should be applied;

c) emitting sufficient focused high intensity focused ultrasound energy to the site in order to raise native tissue temperatures; and

d) inducing tissue and/or blood coagulation at the site.

11. The method of claim 10, wherein the step of determining the site at which thermal energy should be applied further comprises, ultrasonically interrogating a section of the passageway using pulsed Doppler.

12. The method of claim 11, wherein thermal delivery probe has an outer diameter of about 2-7 French or larger.

13. The method of claim 12, wherein the emitted thermal energy is ultrasonically applied using a high frequency, high power output ultrasound transducer.

14. The method of claim 10, wherein the emitted thermal energy is ultrasonically applied using a high frequency, high power output ultrasound transducer.

15. The method of claim 13 or 14, wherein the high frequency, high power output ultrasound transducer is located at a distal end of the thermal delivery probe.

16. The method of claim 13, wherein the high frequency, high power output ultrasound transducer is operated at about 6 MHz and output about 2 W/cm².

17. The method of claim 14, wherein the high frequency, high power output ultrasound transducer is operated at about 6 MHz and output about 2 W/cm².

18. A therapeutic medical device adapted to be inserted into a tissue passageway following a percutaneous medical procedure, comprising:

a) an elongated shaft having a proximal section, a distal section, a distal tip and at least one lumen extending longitudinally from the distal tip to a proximal end located in the proximal section;

b) a means for locating and determining a site at which thermal energy should be applied to promote hemostasis; and

c) a means for emitting sufficient thermal energy to the site thereby raising native tissue temperatures thereby inducing tissue and/or blood coagulation.

19. An insertable probe for delivering thermal energy comprising:

a) a elongated shaft having a proximal end, a distal end, and at least one lumen extending longitudinally form said proximal end to said distal end; and

b) one or more ultrasound transducers positioned in the elongated shaft;

said one or more ultrasound transducers comprising at least one therapeutic ultrasound transducer configured to emit high intensity ultrasound.

20. The insertable probe of claim 19, further comprising a diagnostic ultrasound transducer adapted to ultrasonically interrogate a position in front of the elongated shaft distal end.

21. A method for delivering thermal energy to the tissues, said method comprising:

a) inserting means for heating tissues percutaneously into the body of a patient;

b) determining one or more sites to which thermal energy should be applied;

c) emitting sufficient thermal energy to the site in order to raise native tissue temperatures; and

d) inducing a pre-determined therapeutic affect.